ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 129 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $28,000 | -80.0% | 19,302 | -80.5% | 0.00% | -100.0% |
| Q4 2016 | $140,000 | +13.8% | 98,919 | +40.9% | 0.00% | 0.0% |
| Q3 2016 | $123,000 | +53.8% | 70,221 | +49.3% | 0.00% | 0.0% |
| Q2 2016 | $80,000 | +135.3% | 47,042 | +171.3% | 0.00% | – |
| Q1 2016 | $34,000 | +25.9% | 17,339 | +22.1% | 0.00% | – |
| Q4 2015 | $27,000 | -44.9% | 14,204 | -45.1% | 0.00% | – |
| Q3 2015 | $49,000 | -67.5% | 25,872 | -20.4% | 0.00% | -100.0% |
| Q2 2015 | $151,000 | -33.2% | 32,518 | -37.3% | 0.00% | 0.0% |
| Q1 2015 | $226,000 | -43.6% | 51,827 | -55.2% | 0.00% | -50.0% |
| Q4 2014 | $401,000 | +167.3% | 115,616 | +223.6% | 0.00% | +100.0% |
| Q3 2014 | $150,000 | +64.8% | 35,731 | +129.8% | 0.00% | 0.0% |
| Q2 2014 | $91,000 | -75.4% | 15,548 | -75.4% | 0.00% | -50.0% |
| Q4 2013 | $370,000 | -55.7% | 63,265 | -60.0% | 0.00% | -33.3% |
| Q3 2013 | $835,000 | -43.1% | 158,353 | -16.9% | 0.00% | -57.1% |
| Q2 2013 | $1,467,000 | – | 190,556 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 9,750,000 | $18,623,000 | 1.60% |
| DAFNA Capital Management LLC | 381,600 | $729,000 | 0.72% |
| SENZAR ASSET MANAGEMENT, LLC | 1,766,991 | $3,374,953,000 | 0.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,640,877 | $8,864,000 | 0.34% |
| Lyons Wealth Management, LLC. | 56,665 | $110,000 | 0.14% |
| FEDERATED HERMES, INC. | 5,648,920 | $10,789,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 33,909,459 | $64,767,000 | 0.02% |
| Cubist Systematic Strategies, LLC | 185,166 | $354,000 | 0.02% |
| GAM Holding AG | 523,164 | $997,000 | 0.02% |
| STEVENS CAPITAL MANAGEMENT LP | 191,236 | $365,000 | 0.02% |